GLP-1 stimulates fullness signals to the brain, aiding in greater satisfaction from smaller portions, while GIP enhances your body's insulin regulation and sugar metabolism
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish over time with dose titration
Rahmanian says the two campaigns, both developed in-house, arent different because men and women respond differently to GLP-1 messaging, but because the athletes have such different personalities
The immunomodulatory effects documented in research are systemic anti-inflammatory effects, not targeted autoimmune therapy
Studies have documented cases of pancreatitis, with 7 confirmed cases per 100 patient years in clinical trials [11]